True and false positive rates for different criteria of evaluating statistical evidence from clinical trials

by Don van Ravenzwaaij, John P. A. Ioannidis
Published 2019-11-01

A simulation study of the strength of evidence in the recommendation of medications based on two trials with statistically significant results.

by Don van Ravenzwaaij, John P A Ioannidis
Published 2017-01-01

When numbers fail: do researchers agree on operationalization of published research?

by Matthias Haucke, Rink Hoekstra, Don van Ravenzwaaij
Published 2021-09-01

How best to quantify replication success? A simulation study on the comparison of replication success metrics

by Jasmine Muradchanian, Rink Hoekstra, Henk Kiers, Don van Ravenzwaaij
Published 2021-05-01

When and Why to Replicate: As Easy as 1, 2, 3?

by Sarahanne M. Field, Rink Hoekstra, Laura Bringmann, Don van Ravenzwaaij
Published 2019-09-01

Bayesian reanalysis of null results reported in medicine: Strong yet variable evidence for the absence of treatment effects.

by Rink Hoekstra, Rei Monden, Don van Ravenzwaaij, Eric-Jan Wagenmakers
Published 2018-01-01

Credible Confidence: A Pragmatic View on the Frequentist vs Bayesian Debate

by Casper J. Albers, Henk A. L. Kiers, Don van Ravenzwaaij
Published 2018-08-01

Bayes factors for superiority, non-inferiority, and equivalence designs

by Don van Ravenzwaaij, Rei Monden, Jorge N. Tendeiro, John P. A. Ioannidis
Published 2019-03-01

The effect of preregistration on trust in empirical research findings: results of a registered report

by Sarahanne M. Field, E.-J. Wagenmakers, Henk A. L. Kiers, Rink Hoekstra, Anja F. Ernst, Don van Ravenzwaaij
Published 2020-04-01

Rethinking remdesivir for COVID-19: A Bayesian reanalysis of trial findings.

by Joyce M Hoek, Sarahanne M Field, Ymkje Anna de Vries, Maximilian Linde, Merle-Marie Pittelkow, Jasmine Muradchanian, Don van Ravenzwaaij
Published 2021-01-01